Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | BAX | Q07812 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9770363 | 0.88 | LTA4H (0.45) | LTA4HTSHRCA4CYP1A2GAA | |
| SCHEMBL11577579 | 0.84 | PPARG (0.51) | TSHRSLC6A4 | |
| SCHEMBL28445107 | 0.83 | LTA4H (0.41) | LTA4HTSHRCA4CYP1A2GAA | |
| SCHEMBL3906412 | 0.83 | CA4 (0.50) | LTA4HTSHRCA4CYP1A2GAA | |
| SCHEMBL11340031 | 0.81 | LTA4H (0.39) | LTA4HTSHRCA4KCNA3KDM4E | |
| SCHEMBL11579861 | 0.81 | KCNA3 (0.44) | LTA4HTSHRCA4GAAKCNA3 | |
| SCHEMBL11581977 | 0.81 | PPARG (0.50) | CYP1A2GAAKDM4ESLC6A4LMNA | |
| SCHEMBL29039045 | 0.81 | CA4 (0.42) | LTA4HTSHRCA4CYP1A2GAA | |
| SCHEMBL11580062 | 0.79 | MAPT (0.49) | TSHRCYP1A2GAACYP2C9PKM | |
| SCHEMBL10949753 | 0.79 | SMN1; SMN2 (0.47) | TSHRCYP1A2GAACYP2C9PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115108965-A | Preparation method of anti-neocoronarism drug Parovidekey intermediate | 上海再启生物技术有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-111018825-B | Synthetic method of 2-bromo-3, 4-methylenedioxy-5-methoxybenzoic acid methyl ester | 苏州诚和医药化学有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-111018825-A | Synthetic method of 2-bromo-3, 4-methylenedioxy-5-methoxybenzoic acid methyl ester | 苏州诚和医药化学有限公司 | 2020-04-17 | — | — | CN | claimed |
| WO-1994001394-A1 | PREPARATION OF N-ARYL AMIDES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1994-01-20 | — | — | WO | claimed |
| CN-117069771-A | Metallocene-non-metallocene complex, preparation method thereof and application thereof in preparation of disentangled ultra-high molecular weight polyethylene | 中国科学院长春应用化学研究所 | 2023-11-17 | — | — | CN | disclosed |
| US-20230322742-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | AGILENT TECHNOLOGIES, INC. | 2023-10-12 | — | — | US | disclosed |
| CN-115108965-B | Preparation method of key intermediate of anti-new crown drug Pa Luo Weide | 上海再启生物技术有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-115108965-A | Preparation method of anti-neocoronarism drug Parovidekey intermediate | 上海再启生物技术有限公司 | 2022-09-27 | — | — | CN | disclosed |
| US-11261153-B2 | Organic amine salt compounds having CO2-donating anions and their use as foaming agent | SHANDONG UNIVERSITY OF TECHNOLOGY (CN) | 2022-03-01 | — | — | US | disclosed |
| US-20220035216-A1 | ELECTROCHROMIC ELEMENT, AND METHOD FOR DRIVING THE SAME | RICOH COMPANY, LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| US-11236050-B2 | Polymorphs of 4-[3-chloro-4-(n′-cyclopropyl ureido)phenoxy] -7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereof | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2022-02-01 | — | — | US | disclosed |
| EP-3466916-B1 | ORGANIC AMINE SALT COMPOUND HAVING ANIONS SERVING AS CO2 DONORS AND APPLICATION OF SAME AS FOAMING AGENT | UNIV SHANDONG TECHNOLOGY (CN) | 2021-09-29 | — | — | EP | disclosed |
| US-4136252-A | POLYETHERS, SUSTAINED RELEASE COATINGS | ALZA CORPORATION (US) | 1979-01-23 | — | — | US | disclosed |
| US-4119579-A | Polymeric orthoesters | ALZA CORPORATION (US) | 1978-10-10 | — | — | US | disclosed |
| US-4066747-A | Polymeric orthoesters housing beneficial drug for controlled release therefrom | ALZA CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-3992436-A | Synthesis of oxalate esters from carbon monoxide and carboxylic ortho esters | ATLANTIC RICHFIELD COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3962318-A | Substituted ethane diphosphonic acids and salts and esters thereof | MONSANTO COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3957858-A | SUBSTITUTED ETHANE DIPHOSPHONIC ACIDS AND SALTS AND ESTERS THEREOF | MONSANTO COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
| US-3944599-A | Substituted ethane diphosphonic acids and salts | MONSANTO COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
| US-3940436-A | Substituted ethane diphosphonic acids and salts and esters thereof | MONSANTO COMPANY (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11261153-B2 | Organic amine salt compounds having CO2-donating anions and their use as foaming agent | PHOSPHO1, METTL14, ALKBH3 | LTA4H 2694/4885TSHR 4164/4885CA4 188/4885 |
| US-11236050-B2 | Polymorphs of 4-[3-chloro-4-(n′-cyclopropyl ureido)phenoxy] -7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereof | UGT1A1, CYP4B1, CYP1B1 | LTA4H 3015/4885TSHR 4413/4885CA4 1023/4885 |
| US-20230322742-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | RNGTT, OSBPL8, DCLRE1B | LTA4H 3843/4885TSHR 428/4885CA4 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.